The KMT2D gene helps guide early growth by controlling when many other genes are turned on or off. The protein made by this gene helps your cells follow the right developmental plan in the face, heart, skeleton, and immune system. If you carry a pathogenic variant that greatly reduces its function, it can cause Kabuki syndrome, which often involves developmental delay, distinctive facial features, short stature, and sometimes heart or feeding problems. KMT2D is mainly known in medical genetics rather than popular culture.
What is a gene?
Genes are stretches of DNA that provide instructions cells use to make molecules or regulate activities in the body. Some genes carry the code for proteins, which are the functional parts of cells. Others mostly direct when specific processes happen, where they take place, and how active they are. As a group, genes affect how the body grows and works, and they can also influence how you respond to food, stress, and medicines. For a deeper look at this subject, you can find more in the LearnHub.
Overview
KMT2DGene function
What if the gene works
The KMT2D gene helps control which other genes are turned on and off. This supports normal growth and development, especially in the face, heart, skeleton, and nervous system.
Risk
What if the gene does not work
Variants in the KMT2D gene can cause Kabuki syndrome, with effects on growth, learning, facial features, and sometimes the heart or immune system. Milder or more severe variants may change which features appear and how strongly they affect a person.
Treatment
What does that mean for your treatment
If you carry a pathogenic variant in the KMT2D gene, no KMT2D-specific treatment or drug-selection approach is currently established. The KMT2D gene is being studied in early-stage research as a biomarker and possible drug target, especially in some cancers.
Conditions associated with KMT2D
Gene function
What if the gene works
Your cells rely on the KMT2D gene to help switch many other genes on at the right time and place. It supports the cell’s built in system for organizing DNA activity during growth, development, and everyday tissue function. Understanding how the KMT2D gene works helps explain how cells keep their instructions well coordinated.
The KMT2D gene helps control which genes a cell uses and when it uses them. It does this by shaping how easy it is for the cell to read selected stretches of DNA.
Its protein adds small chemical tags to histones (proteins that package DNA). These tags help create a more ready state for gene control regions to do their job.
This gene supports normal body development by helping cells follow the right activity patterns as tissues form. This careful timing is part of how the KMT2D gene helps control other genes across the body.
Many cells use the KMT2D gene to keep the right sets of genes active for their specific role. This helps a skin cell act like skin and a nerve cell act like nerve tissue.
What is a variant?
Genetic variants are small differences in the DNA sequence of a gene. They are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some cases, though, a variant changes how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the KMT2D gene often weaken how this protein modifies histones (the proteins that package DNA), which can disrupt when other genes are switched on or off. More severe loss-of-function variants, such as early stop or deletion changes, usually leave little or no working protein, while some missense variants may partly reduce stability or interactions. In practice, how KMT2D gene variants affect protein function can influence how early Kabuki syndrome appears and how broad its features are.
How variants are linked to conditions
Disease-causing variants in the KMT2D gene cause Kabuki syndrome, a genetic condition linked to differences in growth, learning, facial features, hearing, and sometimes the heart or immune system. In discussions of the KMT2D gene and Kabuki syndrome, finding a disease-causing variant can confirm the diagnosis.
A variant is not necessarily a diagnosis
Gene variants are a usual part of human biology and are common throughout the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors are involved. In some situations, however, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For KMT2D, risk is mainly determined by whether a disease-causing variant is present, either inherited from a parent or happening for the first time in a child. There is not enough evidence that lifestyle or environmental factors change the chance of having a KMT2D-related condition.
Inheritance of KMT2D variants
KMT2D-related Kabuki syndrome is usually inherited in an autosomal dominant pattern, which means one altered copy of the KMT2D gene can be enough to cause the condition. If a parent carries a disease-causing variant, each child has a 50% chance of inheriting it. In many families, though, a KMT2D gene variant happens for the first time in the child and is not inherited from either parent. This pattern is the main answer to how KMT2D gene inheritance works in affected families.
What does my KMT2D result mean for my family?
For KMT2D, the main family pattern is dominant, which means a parent, brother, sister, or child may also carry the same gene change. If someone living with a KMT2D-related condition has a child, each child has a 1 in 2, or 50%, chance of inheriting it. Some KMT2D changes happen for the first time in one person, so a parent does not always have the same result.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant, KMT2D genetic testing uses a blood or saliva sample to read the KMT2D gene and check for missing or extra pieces. Results may identify a relevant variant, find no relevant change, or show a variant of uncertain significance, which means the health effect is not yet clear.
When should I consider getting a genetic test?
Genetic testing for the KMT2D gene may be considered when a child or adult has signs of Kabuki syndrome, a condition that affects growth and development, or when a close relative has it. A result can help confirm the cause of developmental delays, low muscle tone, heart differences, or other related health issues.
A genetic result is only one part of your health story
A genetic result can be helpful, but how much it explains varies based on the condition and the kind of variant involved. Over time, many factors affect how the body works, including lifestyle, environment, age, and medical history. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when viewed together with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a drug more slowly or more quickly, while others may be more or less sensitive to its effects. This helps explain why the same treatment works well for one person but not as well for another, or why side effects can differ. These differences are common and are one part of the bigger picture alongside age, other health conditions, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can shape a person’s response to medicines. It studies gene and drug patterns to help explain why the same treatment may work differently from one person to another. For many medications, genes can influence either how strongly a drug works or how the body handles it. This information can support treatment decisions that are more informed and more individualized. To explore this subject in greater detail, you can learn more in the LearnHub.
Drugs influenced by the KMT2D gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose. If you have concerns about side effects, unusual reactions, or starting a new medicine, talk with your doctor or pharmacist.
History
Throughout history, people described a recognizable pattern of features now known as Kabuki syndrome, long before its genetic cause was clear. In 2010, researchers identified variants in the KMT2D gene as a major cause of this condition, which marked an important step for diagnosis and research. Initially the gene was commonly called MLL2, and later its name was updated to KMT2D as gene naming became more standardized. From these first observations, research expanded steadily. This discovery helped connect earlier clinical descriptions with a specific inherited cause and gave families a clearer explanation for a condition that had previously been defined only by its outward features.